Investment
Features
FeesSafety
Academy
More
Pluang+
|
Home/News Feed/Clorox rated Hold due to high valuation and leveraged balance sheet post-acquisition, limiting growth and dividend safety.
CLX
$106.19
+$0.15 +0.14%

Clorox rated Hold due to high valuation and leveraged balance sheet post-acquisition, limiting growth and dividend safety.

Analyst Insights
21 Aug 2026
Seeking Alpha
View Source
Bearish
pluang ai news

The Clorox Company is rated Hold as its current valuation demands unsustainable free cash flow growth. While recent positives include the GOJO acquisition and ERP system rollout, organic revenue growth remains limited after adjusting for these factors. The company's balance sheet is heavily leveraged following the acquisition, which restricts reinvestment opportunities and raises concerns about the sustainability of dividends. Despite optimism around wellness trends, the analyst advises caution and recommends waiting for a significant price drop before considering investment.

More News (CLX)

Clorox CEO and CFO to speak at Barclays Global Consumer Staples Conference on Sept 9 with live webcast.

Clorox CEO and CFO to speak at Barclays Global Consumer Staples Conference on Sept 9 with live webcast.

The Clorox Company announced that CEO Linda Rendle and CFO Luc Bellet will participate in a fireside chat at the Barclays Global Consumer Staples Conference on September 9 in Boston. The event will be webcast live and available for replay on Clorox's...

Market News
Neutral
1 day ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App